EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of commercial devices for patient specific QA of stereotactic radiotherapy plans

Shands James, Ahmad Al-Basheer, Eric Elder, Chulhaeng Huh, Christopher Ackerman, John Barrett, Russell Hamilton, Farshad Mostafaei

Journal of Applied Clinical Medical Physics · 2023

DOI: 10.1002/acm2.14009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2023. Verfasst von Shands James und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Medical College of Georgia, Augusta University, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: Radiosurgery, Radiotherapy, Intensity-Modulated. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stereotactic radiotherapy (SRT) methods have become common for the treatment of small tumors in various parts of the body. Small field dosimetry has a unique set of challenges when it comes to the pre‐treatment validation of a radiotherapy plan that involves film dosimetry or high‐resolution detectors. Comparison of commercial quality assurance (QA) devices to the film dosimetry method for pre‐treatment evaluation of stereotactic radiosurgery (SRS), fractionated SRT, and stereotactic body radiation therapy treatment plans have been evaluated in this study. Forty stereotactic QA plans were measured using EBT‐XD film, IBA Matrixx Resolution, SNC ArcCHECK, Varian aS1200 EPID, SNC SRS MapCHECK, and IBA myQA SRS. The results of the commercial devices are compared to the EBT‐XD film dosimetry results for each gamma criteria. Treatment plan characteristics such as modulation factor and target volume were investigated for correlation with the passing rates. It was found that all detectors have greater than 95% passing rates at 3%/3 mm. Passing rates decrease rapidly for ArcCHECK and the Matrixx as criteria became more strict. In contrast, EBT‐XD film, SNC SRS MapCHECK, and IBA myQA SRS passing rates do not decline as rapidly when compared to Matrix Resolution, ArcCHECK, and the EPID. EBT‐XD film, SNC SRS MapCHECK, and IBA myQA SRS maintain greater than 90% passing rate at 2%/1 mm and greater than 80% at 1%/1 mm. Additionally, the ability of these devices to detect changes in dose distribution due to MLC positioning errors was investigated. Ten VMAT SBRT/SRS treatment plans were created with 6 MV FFF or 10 MV FFF beam energies using Eclipse 15.6. A MATLAB script was used to create two MLC positioning error scenarios from the original treatment plan. It was found that errors in MLC positioning were most reliably detected at 2%/1 mm for high‐resolution detectors and that lower‐resolution detectors did not consistently detect MLC positioning errors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryRadiotherapy, Intensity-ModulatedHumansRadiotherapy DosageRadiotherapy Planning, Computer-AssistedQuality Assurance, Health CareRadiometry

Stichwörter der Autor:innen

diodeselectronic portal imaging devicequality assuranceradiochromic filmstereotactic body radiation therapystereotactic radiosurgery

Autor:innen und Institutionen

  • Department of Radiation Oncology, Medical College of Georgia, Augusta University, Augusta, Georgia, USA.
  • Nuclear/Radiological Engineering/Medical Physics Department, Georgia Institute of Technology, Atlanta, Georgia, USA.
  • Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Radiation Oncology, University of Arizona, Tucson, Arizona, USA.

Zitieren

APA

James, S., Al-Basheer, A., Elder, E., Huh, C., Ackerman, C., Barrett, J., Hamilton, R., & Mostafaei, F. (2023). Evaluation of commercial devices for patient specific QA of stereotactic radiotherapy plans. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.14009

Vancouver

James S, Al-Basheer A, Elder E, Huh C, Ackerman C, Barrett J, et al. Evaluation of commercial devices for patient specific QA of stereotactic radiotherapy plans. Journal of Applied Clinical Medical Physics. 2023. doi:10.1002/acm2.14009

BibTeX
@article{James2023,
  author = {James, Shands and Al-Basheer, Ahmad and Elder, Eric and Huh, Chulhaeng and Ackerman, Christopher and Barrett, John and Hamilton, Russell and Mostafaei, Farshad},
  title = {Evaluation of commercial devices for patient specific QA of stereotactic radiotherapy plans},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2023},
  doi = {10.1002/acm2.14009}
}
Kostenlos starten →